Radical change, not tweaking, is neededBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b5656 (Published 31 December 2009) Cite this as: BMJ 2009;339:b5656
- John H Noble Jr, emeritus professor1
- 1State University of New York at Buffalo
Lawton makes the case against major reform of the way the pharmaceutical and medical device industry currently does business against Goldacre’s call for the conduct of clinical trials by disinterested third parties to offset the inherent biases of industry sponsored clinical trials.1 2 He dismisses Goldacre’s argument that …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial